MIM
ARA

MetLife Investment Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

MetLife Investment Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,580
Closed -$63.3K – 2390
2020
Q1 		$63.3K Buy
+9,580
New +$83.5K ﹤0.01% 2217
2018
Q4 		– Sell
-6,805
Closed -$147K – 2615
2018
Q3 		$147K Buy
+6,805
New +$129K ﹤0.01% 2251

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MetLife Investment Management's ARA Position: Q2 2020 in Review

MetLife Investment Management sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2020, closing a stake of 9,580 shares — an estimated $63.3K sold.

MetLife Investment Management first reported a position in ARA in Q3 2018 and held it in 2 quarters. The position peaked at $147K in Q3 2018. 56 funds tracked by Wall St. Rank hold ARA as of Q2 2020.

  • MetLife Investment Management reported no remaining American Renal Associates Holdings, Inc position as of Q2 2020 after selling out during the quarter.
  • MetLife Investment Management sold 9,580 American Renal Associates Holdings, Inc shares in Q2 2020, an estimated $63.3K.
  • MetLife Investment Management first reported a position in American Renal Associates Holdings, Inc in Q3 2018 and held it in 2 quarters.
  • MetLife Investment Management's American Renal Associates Holdings, Inc position peaked at $147K in Q3 2018.
  • 56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2020.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.